Events

AXIS Consulting are once again proud to be the Platinum sponsor of The Pharmaceutical Managers Institute (PMI) Pharma Summit which takes place on  Thursday, 18^th of April 2024 in the Croke Park Convention Centre, Dublin.

The theme of the Pharma Summit this year is “Exploring the Diverse Value of Irish Healthcare” and will involve many keynote speakers and a panel discussion chaired by AXIS Founder and CEO, Brenda Dooley and featuring significant contributions from AXIS Head of HTA Consulting, UK, Carl Prescott.

The panel discussion is entitled “Payers & Providers: The Value of Partnership –Striking a balance between the values of innovation, affordability & continuity of supply” and Carl will be joined by Caitriona Duggan, Country Manager – Amgen & Chair of Market Access Advisory Forum – IPHA, Deirdre Kelly, Country Manager – Consilient Health & Vice Chair – Medicines for Ireland and Angela Clayton-Lea, Acting CEO – Clinical Trials Ireland.

Additionally, the AXIS team, Allister Upton, Head of HTA, Ireland, Laura Rouncivell, HTA Value & Strategy Lead, Ireland and Caroline McNeill, Business Operations Lead, will be delighted to connect with those in attendance on the day, so be sure and drop by the AXIS stand.

More information and to secure your ticket please click here.

AXIS Consulting had a strong presence at ISPOR Europe 2023, with Brenda Dooley (CEO), Steve Beard (Business Insights Advisor), Caroline McNeill (Business Operations Lead), Laura Rouncivell (HTA Value and Access Strategy Lead), Emer Gribbon (Associate) and Fauve Aylmer (Clinical Research Assiatant travelling to Copenhagen for the event. ISPOR Europe ran from Sunday, November 12th, to Wednesday, November 15th, and AXIS were exhibiting at Stand C2-013.

In addition to our presence in the exhibition space, on Monday 13th, AXIS presented to a full audience, a fascinating Theatre Session, with the theme: ‘Artificial Intelligence and Machine Learning tools at the heart of future NICE evaluations…a prospect or a pipe dream?’

Alongside this, AXIS Consulting had been selected for three Poster Sessions, with representatives from the company presenting on various themes.

On Tuesday, November 14th, AXIS hosted a very successful Networking Event at our exhibition stand where attendees were treated to an Irish Coffee Reception.

The AXIS Consulting team were on the road once again, and attended the World Orphan Drug Congress in Barcelona. The event ran from Monday, October 30th, to Thursday, November 2nd, AXIS Consulting  exhibited at Stand 96. Brenda Dooley (CEO), Laura Rouncivell (HTA Value and Access Strategy Lead) and Caroline McNeill (Business Operations Lead) and Fauve Aylmer (Clinical Research Assistant) were in attendance in Barcelona.

The PMI will host its next masterclass on Thursday the 1st of June where they will explore the pharmaceutical industry from drug discovery to dispensing.

AXIS Consulting Ireland & UK Founder and CEO, Brenda Dooley is delighted to be presenting at this masterclass on the MFI and IPHA code overview, as well as speaking on the essentials of Market Access in Ireland.

The event is suited to those who are curious about the pharmaceutical industry and want to learn more about the journey that a medicine undergoes from drug discovery to being dispensed in a retail pharmacy.

See below the range of topics and activities that will take place on the day.

• Market Data
• Warehouse Tour
• Stakeholder Overview – HSE / CPU / NCPE / DoH / Primary & Secondary Care Network
• Regulatory / Drug Discovery
• Route to Market / Commercial Excellence
• Pricing Overview – ex factory / wholesale price
• Market Access 101 – HTA, Rapid Review, MMP
• MFI/IPHA Code Overview

For more information or to secure your place at this event, see here.

AXIS Consulting Ireland & UK Founder and CEO, Brenda Dooley will be a panellist at a key session at the 2023 Dublin Tech Summit in the RDS on Thursday the 1st of June.

The session titled: From Local Start-up to Global Success: Scaling Internationally will be moderated by Oliver Daniels, CEO and Director of Global Entrepreneurship and Innovation at the Galway Technology Centre.

At this fireside chat, Brenda will speak to the success of AXIS Consulting from a start-up in 2012 to scaling the business internationally in the UK and BeNeLuxA by 2023. On the day, Brenda will join a superb panel on the day including:

• Fergal O’Connor – Founder and CEO of Buymedia
• Steve Lenox – Director of Choose New Jersey
• Dave Silke – Chief Marketing Officer of Centripetal

More information on the Dublin Tech Summit is available here.

The PM Society Market Access Special Interest Group (MAIG) hosted their first in-person event Tuesday 23rd of May in London from 1pm to 6pm. 

The event titled: Securing Market Access to Medicines for England, Ireland, Scotland Wales – The Landscape Ahead delved into the key issues facing the UK and Irish Healthcare systems and address the crucial factors in securing market access for medicines in these areas.

This event was organised and was led by the MAIG Co-Chairs Brenda Dooley, CEO and Founder of AXIS Consulting UK &Ireland and Esther Nzenza, CEO of Decisive Consulting. Guest Speakers at this event included: 

• Dr Andree Bates, Chairman of the Board/Founder/CEO, Eularis
• Mr. Sean Richardson, VP & General Manager UK & Ireland, Alexion, AstraZeneca Rare Disease
• Mr. Leslie Galloway, Chairperson, EMIG
• Mr. Blake Dark formerly Commercial Medicines Director, NHS England
• Mr. Brad Groves, Director, NICE Scientific Advice
• Ms. Silvy Mardiguian, Market Access Director UK & Ireland, BeiGene
• Ms. Brenda Dooley, Founder and CEO, AXIS Consulting
• Ms. Esther Nzenza, Founder and CEO, Decisive Consulting Ltd

To learn more about this event, see here. 

AXIS Consulting UK & Ireland was delighted to attend and exhibit at the  Association of British Pharmaceutical Industry (ABPI) Annual Conference.

The theme for the ABPI 2023 Conference was Growing the UK as a Global Hub for Life Science.

The Conference focused on delivering the shared goal between industry and Government to make the UK the best place to research, develop and use the medicines and vaccines of the future.

More information on this event is available here.

AXIS Consulting was proud to be the Platinum sponsor of The Pharmaceutical Managers Institute (PMI) Pharma Summit on Thursday, the 30^th of March 2023. This event took place in the Croke Park Convention Centre, Dublin

The theme of the Pharma Summit was “Partnering to Improve Human Health” and was explored from four vantage points: Technology, Government, Cross Company and Intra Company. The event involved many keynote speakers and panel discussions featuring significant contributions from the AXIS Consulting team.

AXIS CEO, Brenda Dooley chaired the panel discussion titled: Creating Optimal Stakeholder Partnerships: Can cross industry working & innovative internal organisation accelerate innovation & access?

She was joined by a fantastic line-up of panellists for this session, including:

• Michael O’Connell, General Manager – Biogen & President – IPHA
• Alison Muir, General Manager – Roche Ireland
• Padraic O’Brien, Managing Director – Accord Healthcare & Chair -Medicines for Ireland

Additionally, Team AXIS were delighted to connect will all in attendance on the day as well as exhibit at the PMI Pharma Summit.

More information on this event can be found here.

AXIS Consulting UK and Ireland CEO CEO Brenda Dooley represented the company at the Celtic National Quarterly NHS Insight panel session.

This event was led by Ian Chamberlain, Director and Founder of the Life Science Access Academy brought together a panel of experts to explore how the Celtic Nations are progressing in the current environment of winter pressures, the COVID-19 aftermath, delayed bed discharges and NHS strikes.

Brenda joined a fantastic line-up of panellists who looked at the impact of the increasing waiting lists across the healthcare systems, the importance of relevant data gathering to support product applications and why value proposition needs to be aligned with current healthcare strategies.

EMIG Scotland hosted its first in-person meeting on Thursday the 23rd of March in Norton House Hotel Edinburgh.

The event saw Brenda Dooley the CEO of AXIS Consulting UK and Ireland and the Managing Secretariat of EMIG, act as the MC for this insightful meeting.

Two wonderful guest speakers presented at the event:

• Professor Sir Michael Ferguson, – Regius Professor of Life Sciences, at Dundee University, Scotland
• Sharon Pfleger – Consultant in Pharmaceutical Health at NHS Highland

For more information or for any queries on the EMIG Member events, please contact jill.payne@emig.org.uk

The EMIG Market Access Special Interest Group hosted its first in-person meeting of the year, on Thursday the 2^nd of March in London. This event saw Marian Hernon, the Associate Director of AXIS Consulting present at the meeting where she spoke on the Pricing and Reimbursement Landscape for Ireland in 2023 and what you need to know.

Additionally, Leslie Galloway, the chairperson of EMIG provided an update on the organisation.

For more information or for any queries on this event, please contact  jill.payne@emig.org.uk

AXIS Consulting was proud to host Ireland’s First Ever Patient Access Conference on Thursday, February 23rd, in the Royal College of Physicians Ireland, Dublin 2. The fully booked event heard from some of the leading lights in the Irish healthcare system and it is hoped will act as a catalyst to unite all stakeholders, with a view to enhancing access to new and innovative medicines for patients in Ireland.

More information on this event can be found here.

The final EMIG Scotland meeting of 2022 was held virtually on Wednesday the 7^th of December 2022.

Brenda Dooley, the Managing Secretariat of EMIG Scotland and CEO of AXIS Scotland arranged an excellent line-up of speakers for this event. The speakers for this event can be found here.

Enquiries about this event can be made to jill.payne@emig.org.uk 

AXIS Consulting was the proud sponsor of the final PMI stakeholder briefing of 2022 on December 5th. At this virtual event, we heard from Prof Áine Carroll, Chair of the HSE Drugs Board as well as Brenda Dooley, Founder and CEO of AXIS.

During her talk, Prof Carroll gave attendees an overview on:

• How a medicine moves through the reimbursement system
• Which HSE body manages the process and when they step in and out
• How to improve the quality of submissions and avoid common pitfalls/errors

Meanwhile, Brenda gave a brief overview of the AXIS poster unveiled at the ISPOR Europe conference which relates to the reimbursement journey in Ireland.

This event was a fantastic opportunity for attendees to pose their questions on the Irish reimbursement system to both Prof Áine Carroll and Brenda Dooley.

AXIS Consulting was one of the main exhibitors at the ISPOR Europe 2022 conference in Vienna on the 6th – 9th of November. 

At the event, AXIS unveiled its new look to mark the company’s expansion into Scotland and BeNeLuxA region. 

We also presented 4 posters at the conference reflecting research that has been conducted by Team AXIS over recent months. 

Do you find it challenging to understand the evolving Irish market access landscape?  Have your questions answered at the renowned AXIS Consulting Market Access Masterclass.

Celebrating its 10^th year in business, AXIS Consulting was delighted to host one of its acclaimed masterclasses once again following the success of our previous masterclasses.

This half-day masterclass took place virtually on Friday the 30^th of September 2022.

As the dominant providers of submissions to the Irish authorities, the expert team at AXIS are leaders in the development of robust reimbursement submissions and have unrivalled experience of submissions locally, with record success rates.

During this interactive masterclass, our team guided attendees through:

• The latest developments in the reimbursement and market access landscape in Ireland
• The key components of a reimbursement application
• How to avoid the most common mistakes with both Rapid Review and full HTA submissions

AXIS Consulting was delighted to attend and exhibit at the annual conference of The Association of the British Pharmaceutical Industry (ABPI) “Delivering the UK’s Life Sciences Vision” held at the BMA House, Tavistock Square London.

This event took place on Thursday the 30^th of June and covered all areas of the Vision, including building the UK’s science and research Infrastructure; creating an outstanding environment for life sciences across regulation, manufacturing, trade, and skills; and importantly delivering access to new medicines and technologies.

Members of our team including our Founder and CEO Brenda Dooley were present at the event to connect with all in attendance and shared our expert insight and more information about our services that support dual submissions to the SMC and NCPE over parallel timelines. As AXIS celebrates its 10^th year in operations, the team are committed to being your trusted market access partner for Scotland, Ireland and BeNeLuxA.

In 2021, the new framework agreement regarding the supply and pricing of medicines for Ireland was published. These agreements between The Irish Pharmaceutical Healthcare Association (IPHA) Medicines for Ireland (MFI) and the state authorities comprising of the Department of Health (DOH), Department of Public Expenditure and Reform (DEPR) and the Health Service Executive (HSE) set the reimbursement terms and conditions for all new and existing medicines for the period 2021-2025.

At the EUCOPE Pricing and Reimbursement/ Market Access Working Group Meeting on Wednesday the 8th of June, Brenda Dooley, Chief Executive Officer and Cillian Copeland, Senior HTA Manager both of AXIS Consulting shared their perspective and insights on these agreements. Their presentation focused on the implications for those working in Market Access in Ireland and will be of value to anyone who has an interest in or is responsible for making pricing and reimbursement applications to the Irish Authorities.

AXIS Consulting  was proud to sponsor the Pharmaceutical Managers Institute Pharma Summit 2022 on the 19th of May. The Annual Summit was held in Fitzpatrick Castle Hotel, Killiney and was a celebration of the innovators and trailblazers at the very heart of the healthcare industry. 

Our team were present at the event to connect with all in attendance and provided insight into the reimbursement process in Ireland while also sharing  best practice gained from the successful experiences of AXIS over the past 10 years in Ireland and internationally. 

As we are all aware new framework agreements on the supply and pricing of medicines for Ireland were published in late 2021. The agreements between The Irish Pharmaceutical Healthcare Association (IPHA), Medicines for Ireland (MFI) and the state authorities comprising the Department of Health (DOH), Department of Public Expenditure and Reform ( DEPR) and the Health Service Executive (HSE) set the reimbursement terms and conditions for all new and existing medicines for the period 2021 –2025.

At the PMI breakfast meeting on Wednesday, March 9^th, Brenda Dooley, Chief Executive at AXIS along with her colleague Senior HTA Manager Cillian Copeland, will focus on the key implications for those of us working in Market Access in Ireland. This will be an important event for anyone who has an interest in or is responsible for making pricing and reimbursement applications to the Irish authorities.

As you will be aware a new framework agreement on the supply and pricing of medicines for Ireland was published on December 6^th, 2021. This new agreement sets out the reimbursement terms and conditions for all new and existing medicines for the period October 1^st, 2021 – 30^th September 2025.

At the webinar, CEO Brenda Dooley along with  Cillian Copeland, HTA Manager, will shine the spotlight on what’s new in this agreement and tease out the key implications for pharmaceutical companies who are making pricing and reimbursement applications to the Irish authorities.

We are delighted to announce that Jim McGrath, Director of Commercial Policy at the Irish Pharmaceutical Healthcare Association (IPHA) will join the webinar as our guest presenter. Jim will speak about IPHA’s role in negotiating a new agreement with the other key stakeholders, the Department of Health, the Department of Public Expenditure and Reform and the Health Service Executive.

This free of charge event is for pharmaceutical company employees only. Places are limited so if you wish to attend, please book your place now by emailing Kavi Burke, Operations Manager: Kavi@axisconsulting.ie

The half day masterclass will focus on updates in the Irish pricing & reimbursement landscape and cover tips for making robust reimbursement submissions to the NCPE as well as how to prepare for price negotiations/discussions with the HSE.
If you are working in market access and reimbursement in Ireland, this is an event not to be missed.

Attendance is free, numbers limited.

The biannual AXIS Masterclasses are well received by industry professionals as a source of up to the minute information on the Irish Market Access landscape.

Click Here for the full agenda!

This event is intended for industry professionals working for pharmaceutical and MedTech firms.

The PMI is delighted to welcome Paul Reid back to give their members an update on:

• where the HSE is versus plan
• how the HSE has coped during the Covid pandemic & cyber attack
• update on Sláintecare
• impact of Covid on other therapy areas & on the general healthcare budget
• what the next 12 months holds

As event sponsors, AXIS Consulting will present key findings from research the team have recently conducted on the “In-between timeline” of the NCPE Assessment process on submitted HTAs.

Over the past two years, AXIS has assessed the timelines in between the NCPE published submissions dates to ascertain the average period of time involved in the process and whether that differs from particular medicines such as Cancer medicines. The findings will be helpful to all in understanding the time the various components of the process take and will be very useful information for companies in their HTA submissions.

Who should attend this event?

Clients of AXIS Consulting, members, affiliates and stakeholders of IPHA as well as EFPIA members in Belgium, Luxembourg, Netherlands & Austria are invited to attend this free webinar.

Why should you attend this event?

The aim of the BeNeLuxAI initiative is to ensure sustainable access and affordable use of innovative medicines for patients. Over recent years the BeNeLuxAI collaborative has completed joint HTA assessments for a number of medicines. It is therefore timely to consider the key developments within the group and hear of the learnings of this joint collaborative comprising Belgium, Netherlands, Luxembourg, Austria and Ireland.
In addition to covering developments at BeNeLuxAI and the role of the pharmaceutical industry group in such collaborations, this webinar also provides an opportunity to hear about important updates on the International Horizon Scanning Initiative.

Are you a Market Access Strategist based in Ireland or the UK with responsibility for developing a reimbursement submission to the Irish HTA assessment agency, the NCPE? Do you find it challenging to keep up to date with all the challenges in the Irish market access landscape? Would you like to be updated on and understand key changes occurring in 2021? 

Don’t miss our Spring 2021 Virtual Market Access Masterclass, normally a one-day event, this year’s masterclass will take place online over two half days. The virtual masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.

• Fri, March 19, 2021 & Wed, March 24, 2021
• 9:00am – 12:30pm BST
• Virtual event
• Book Now